Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study

Denholm, Justin T., McBryde, Emma S., Eisen, Damon P., Penington, Jocelyn S., Chen, Caroline, and Street, Alan C. (2014) Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study. Drug, Healthcare and Patient Safety, 2014 (6). pp. 145-149.

[img]
Preview
PDF (Published Version) - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (158kB) | Preview
View at Publisher Website: http://dx.doi.org/10.2147/DHPS.S68837
 
17
84


Abstract

Introduction: Isoniazid preventative therapy (IPT) is a widely used intervention for treatment of latent tuberculosis infection (LTBI), particularly in patients at high risk for reactivation. While treatment-limiting adverse effects have been well studied, few prospective studies have considered the range of adverse effects that patients may experience with IPT.

Methods: All patients commencing treatment for LTBI were prospectively enrolled in an ongoing database of LTBI treatment outcomes particularly related to adverse effects, treatment adherence, and treatment completion.

Results: Data on the first 100 patients who were prescribed IPT are presented. Fifty-six patients reported at least one adverse effect at some stage during treatment, with six experiencing at least one World Health Organization (WHO) Grade 3–4 adverse effect. Increased age was significantly associated with risk of adverse effects (odds ratio [OR] =1.05 per year; confidence interval [CI] of 1.02–1.08=95%). Eighty-five patients had documented completion of therapy locally, with ten patients ceasing IPT due to adverse effects.

Discussion: This report highlights a variety of somatic adverse effects that occurred in a real-world cohort of patients receiving IPT. While adverse effects were frequently identified in this study, the considerable majority were low grade and transient. Despite frequent adverse effects of LTBI in our treatment cohort, the study demonstrated high levels of treatment adherence and completion.

Item ID: 39744
Item Type: Article (Research - C1)
ISSN: 1179-1365
Keywords: latent tuberculosis infection, isoniazid preventative therapy, treatment toxicity
Additional Information:

This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License.

Funders: John Burge Trust Fund
Date Deposited: 06 Oct 2015 01:50
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1103 Clinical Sciences > 110309 Infectious Diseases @ 40%
11 MEDICAL AND HEALTH SCIENCES > 1117 Public Health and Health Services > 111706 Epidemiology @ 40%
16 STUDIES IN HUMAN SOCIETY > 1605 Policy and Administration > 160508 Health Policy @ 20%
SEO Codes: 92 HEALTH > 9202 Health and Support Services > 920207 Health Policy Evaluation @ 50%
92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920109 Infectious Diseases @ 50%
Downloads: Total: 84
Last 12 Months: 34
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page